Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation Results From the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Study

被引：62

作者：

Flaker, Greg ^{[1
]}

Ezekowitz, Michael ^{[1
]}

Yusuf, Salim ^{[1
]}

Wallentin, Lars ^{[1
]}

Noack, Herbert ^{[1
]}

Brueckmann, Martina ^{[1
]}

Reilly, Paul ^{[1
]}

Hohnloser, Stefan H. ^{[1
]}

Connolly, Stuart ^{[1
]}

机构：

[1] Univ Missouri, Columbia, MO 65212 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 59卷 / 09期

关键词：

D O I：

10.1016/j.jacc.2011.10.896

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：854 / 855

页数：2

共 1 条

[1] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

← 1 →